SG Americas Securities, LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$67,000
-19.3%
21,294
-25.2%
0.00%
-100.0%
Q2 2020$83,000
-57.0%
28,465
-58.4%
0.00%
-50.0%
Q1 2020$193,000
+141.2%
68,387
+176.4%
0.00%
+100.0%
Q4 2019$80,000
-57.0%
24,744
-71.2%
0.00%
-50.0%
Q3 2019$186,000
+40.9%
86,058
+104.1%
0.00%
+100.0%
Q2 2019$132,000
-64.8%
42,172
-58.1%
0.00%
-66.7%
Q1 2019$375,000
+476.9%
100,722
+350.6%
0.00%
+200.0%
Q4 2018$65,000
+109.7%
22,351
+90.6%
0.00%
Q3 2018$31,000
-97.4%
11,728
-97.7%
0.00%
-100.0%
Q2 2018$1,189,000
-64.0%
508,218
-54.8%
0.01%
-57.7%
Q1 2018$3,303,000
+46.5%
1,123,615
+36.6%
0.03%
+23.8%
Q4 2017$2,254,000
+2223.7%
822,790
+2789.8%
0.02%
+2000.0%
Q3 2017$97,000
-25.4%
28,472
-53.6%
0.00%0.0%
Q4 2016$130,000
+31.3%
61,353
+108.1%
0.00%0.0%
Q3 2016$99,000
+83.3%
29,483
+82.3%
0.00%
Q1 2016$54,000
-34.1%
16,176
-29.9%
0.00%
-100.0%
Q4 2015$82,000
-90.5%
23,089
-86.5%
0.00%
-80.0%
Q3 2015$862,000
-66.9%
171,345
-57.8%
0.01%
-70.6%
Q2 2015$2,608,000
+216.1%
405,652
+245.8%
0.02%
+240.0%
Q1 2015$825,000
-72.4%
117,305
-69.7%
0.01%
-66.7%
Q4 2014$2,989,000
+1271.1%
387,702
+1226.7%
0.02%
+1400.0%
Q3 2014$218,000
-25.3%
29,224
-3.3%
0.00%
-50.0%
Q2 2014$292,000
+44.6%
30,213
+19.1%
0.00%
+100.0%
Q3 2013$202,000
+90.6%
25,359
+85.2%
0.00%0.0%
Q2 2013$106,00013,6960.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders